Cambridge researchers say detailed genetic characterisation including whole genome sequencing can help ensure safety of cell-based therapies.Read more
Up to 1,700 more patients from across the UK are being asked to join an Addenbrooke’s led drug trial, to help find ways of protecting those with poor immunity from catching Covid.Read more
Researchers at the University of Cambridge have shown that genetic mutations associated with kidney cancer rely on factors that regulate normal kidney cells in order to develop into cancer cells.
The study suggests Read more